Showing results (101-110 of 196) with videos related to

Sort By:
Pageof 20
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2019
DNA threads released by activated CD4+ T lymphocytes provide autocrine costimulationMassimo Costanza, Pietro L Poliani, Paola Portararo, et al.
Cancer Immunology, Immunotherapy : CII|February 15, 2002
Vaccination of stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cellsMichele Maio, Ester Fonsatti, Elda Lamaj, et al.
Cancer Research|November 1, 2008
Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasisSabina Sangaletti, Emma Di Carlo, Silvia Gariboldi, et al.
Epigenomics|March 26, 2024
Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell responseIrene Fischetti, Laura Botti, Roberta Sulsenti, et al.
Journal of Leukocyte Biology|February 28, 2016
IFN-α promotes rapid human Treg contraction and late Th1-like Treg decreaseIlenia Pacella, Eleonora Timperi, Daniele Accapezzato, et al.
Biomedicines|February 25, 2023
Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot StudyFrancesca La Gualana, Francesca Maiorca, Ramona Marrapodi, et al.
Molecular Cancer|December 12, 2022
Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signalingCeleste Rizzello, Valeria Cancila, Sabina Sangaletti, et al.
Cancer Research|July 25, 2015
Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor GrowthAlice Rigoni, Lucia Bongiovanni, Alessia Burocchi, et al.
Inflammatory Bowel Diseases|December 23, 2017
Separation of Dual Oxidase 2 and Lactoperoxidase Expression in Intestinal Crypts and Species Differences May Limit Hydrogen Peroxide Scavenging During Mucosal Healing in Mice and HumansAlice Rigoni, Richard Poulsom, Rosemary Jeffery, et al.
Oncoimmunology|September 18, 2018
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesisPatrizia Nanni, Carla De Giovanni, Alessia Burocchi, et al.
Pageof 20